Global Solutions for Infectious Diseases

AIDSVAX^® Research Collaborators

Following its mission, GSID has established numerous research collaborations with researchers from both the public and private sectors and academia around the world. We serve as investigational product sponsors by providing AIDSVAX^® vaccine to clinical trial sponsors, such as the USMHRP and the NIH. We also collaborate by providing our vaccine, rgp120 reagents, serological specimens and clinical study data to other researcher who are planning the next large-scale HIV vaccine efficacy trials, developing the next generation of HIV vaccines or conduction experiments to better understand why AIDSVAX^® B/E was prominent in the partial efficacy demonstrated in RV 144.

If you are interested in collaborating with GSID on our AIDSVAX research, please follow the directions here.

AIDSVAX^® Research Collaborations
No.	Collaborating Institution	Investigator(s)	Type of Collaboration
1	Armed Forces Research Institute for Medical Sciences (AFRIMS)*	o'Connell, Karasawa, Excler, et.al.	vaccine, rgp 120 reagents, serological specimens
2	CHUV (Centre Hospitalier Universitaire Vadois)*	Pantaleo	clinical study, vaccine
3	Dartmouth College	Ackerman	serological specimens
4	Duke University, Department of Medicine, Human Vaccine Institute	Haynes, Montefiori, Tomares, Moody, et.al.	rgp 120 reagents, serological specimens, clinical study
5	EuroVacc Foundation*	Pantaleo	clinical studies, vaccine
6	Fred C. Hutchinson Cancer Research Center*	Gilbert, McElrath, Frahm	clinical study data,rgp 120 reagents
7	GeoVax (private sector company)	Robinson	clinical study
8	Harvard University/Beth Israel Deaconess Medical Center*	Barouch, Shanta	vaccine
9	HIV Vaccine Trials Network (HVTN)*	Various	clinical studies
10	International AIDS Vaccine Initiative (IAVI)	Priddy	clinical study
11	Immunetics (private sector company)*	Levine	serological specimens
12	iPox Foundation*	Pantaleo	clinical studies
13	Joan & Sanford I. Weil Medical College of Cornell University	Moore	rgp 120 reagents, serological specimens
14	Los Alamos National Lab	Korber	serological specimens
15	Massachusetts General Hospital (Ragon Institute)*	Alter	serological specimens
16	Massachusetts Institute of Technology	Lowe	serological specimens
17	National Institutes of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID) / Division of AIDS (DAIDS)*	Various	clinical studies, serological specimens
18	NIH / NIAID -Vaccine Research Center*	Koup, Bailer, Anthos Wyatt, Mascola	rgp 120 reagents, serological specimens
19	NIH - Biostatistics Research Branch of the Division of Clinical Research	Follmann	clinical study data
20	New York University Langone School of Medicine*	Zolla-Pazner, Marmor, Cardozo	serological specimens, clinical study data
21	New York University/Veteran's Administration New York Harbor Healthcare System*	Hioe	rgp 120 reagents, serological specimens
22	PaxVax (private sector company)	Gurwith, Connors	clinical study
23	Rockefeller University/Howard Hughes Medical Institute	Neuaezweig	vaccine
24	Rush University Medical Center	Baum	rgp 120 reagents
25	San Francisco Department of Public Health	Buchbinder	clinical study data
26	Sanofi Pasteur (private sector company)*	Tartaglia, Phogat, et.al.	clinical studies
27	SRI International	Wang	serological samples
28	Tulane University	Weazy	vaccine
29	University of Alabama, Birmingham*	Shaw, Hahn, Bar	serological specimens
30	University of California, Irvine*	Forthal	rgp 120 reagents
31	University of California, San Francisco*	Wittington	clinical study data
32	University of California, Santa Cruz*	Berman	rgp 120 reagents, serological specimens
33	University of Kansas	Desaire	rgp 120 reagents
34	University of Maryland, Baltimore	DeVico	vaccine, serological specimens
35	University of Melbourne	Kent	rgp 120 reagents
36	University of Nebraska, Lincoln*	Li	vaccine, rgp 120 reagents
37	University of North Carolina, Charlotte	Sun	clinical study data
38	University of Pennsylvania*	Shaw, Hahn, Bar	serological specimens
39	University of Washington	Greenberg, Goodreau	vaccine, clinical study data
40	US Food & Drug Administration	Krause	vaccine
41	US Military HIV Research Program (MHRP) and Walter Reed Army Institute of Research (WRAIR)*	Michael, Kim, Robb, et.al.	clinical studies, vaccine, rgp 120 reagents, serological specimens
42	Vanderbilt University	Crowe	serological specimens
43	University of Rochester	Johnson	Clinical study data
44	University of JAEN (Spain)	Caruz	Clinical study data
45	University of Rochester	Johnson	Clinical study data
46	Ohio State University	Ganesan	serological specimens
47	Imperial College, London	Weber	Clinical study, vaccine, rgp 120 reagents
48	Mt. Sinai Health System	Hioe	rgp reagents
49	University of Georgia	Song	VAX004 database subset
* With these institutions, GSID has entered into multiple cooperative research and development, clinical trial and material transfer agreements.

Additional Resources

CNN International provides an update on the PrEPVacc clinical trial
[more]

Legal Notice • Site Map